JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.32, ss.450-460, 2015 (SCI-Expanded)
Background: Early brain injury and cerebral vasospasm are major factors determining outcome for patients who experience subarachnoid hemorrhage (SAH). This study was performed to investigate the potential therapeutic effects of zoledronic acid on cerebral vasospasm in an experimental SAH model.